8.46MMarket Cap-240P/E (TTM)
4.1780High3.8900Low28.66KVolume3.9100Open3.9650Pre Close114.69KTurnover2.41%Turnover RatioLossP/E (Static)2.11MShares23.750052wk High0.45P/B4.75MFloat Cap3.400052wk Low--Dividend TTM1.19MShs Float800.0000Historical High--Div YieldTTM7.26%Amplitude3.4000Historical Low4.0020Avg Price1Lot Size
NuCana Stock Forum
NEWS
NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement
Watching for a post R/S pop?
Update
Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy
Clinical Study
NUC-7738 Reprograms Cancer Cell Lipid Metabolism to Make Tumors Less Aggressive
and Promote Cancer Cell Death
NUC-7738 Alters Ribosome Biogenesis and the Regulation of Genes Critical for Cancer
Growth and Survival
San Diego, California April 9, 2024 (GLOBE NEWSWIRE)- NuCana plc (NASDAQ: NCNA) announced two posters be...
NEWS
NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study
NuCana plc (NASDAQ: NCNA) presented two posters at the AACR Annual Meeting showcasing the effects of NUC-7738 on cancer cell lipid metabolism and ribosome biogenesis. NUC-7738 was found to reprogram lipid metabolism in tumors, making them less aggressive and promoting cancer cell death. The drug alters genes critica...
Sinking ship
No comment yet